Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males

NCT06721091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: VNA-318
DRUG: Placebo

Sponsor

VANDRIA

Collaborators

[object Object]